Search all trials

Find therapies in clinical trials near you – page 13

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Porphyria non-acute

Not recruiting

InvestigationalNo placebo

Study on the Safety and Tolerability of Oral Dersimelagon for Patients with Erythropoietic Protoporphyria or X-Linked Protoporphyria

InvestigationalNo placebo

Sweden

Participants:0–17 years · 18–64 years · 65+ years
Substances:Dersimelagon Phosphate

Contact Research Centre

IgA nephropathy

Not recruiting

Investigational

Study on the Effectiveness and Safety of Iptacopan for Patients with Primary IgA Nephropathy

Investigational

Sweden

Participants:18–64 years · 65+ years
Substances:Iptacopan

Contact Research Centre

Plasma cell myeloma refractory

Not recruiting

Registered drugNo placebo

Study of Teclistamab for Patients with Relapsed or Refractory Multiple Myeloma

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Teclistamab

Contact Research Centre

Acute myeloid leukaemia+1

Not recruiting

Registered drugNo placebo

Study Comparing Gilteritinib and Midostaurin with Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome with FLT3 Mutation

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Gilteritinib

Contact Research Centre

Neurodegenerative disorder

Not recruiting

InvestigationalNo placebo

Study of Latozinemab for Patients with Neurodegenerative Diseases Who Previously Participated in a Latozinemab Study

InvestigationalNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Latozinemab

Contact Research Centre

Demyelination

Not recruiting

Registered drug

Study on the Effectiveness and Safety of Rozanolixizumab for Adults with Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOG-AD)

Registered drug

Sweden

Participants:18–64 years · 65+ years
Substances:Rozanolixizumab

Contact Research Centre

Plasma cell myeloma

Not recruiting

Registered drugNo placebo

Study Comparing Teclistamab, Talquetamab, and Drug Combination for Patients with Newly Diagnosed Multiple Myeloma Not Suitable for Stem Cell Transplant

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Daratumumab

Contact Research Centre

Polycythaemia vera+10

Not recruiting

Registered drugNo placebo

Study on Long-Term Safety of Ruxolitinib, Panobinostat, and Siremadlin for Patients Continuing Treatment from Previous Studies

Registered drugNo placebo

Sweden

Participants:0–17 years · 18–64 years · 65+ years
Substances:Panobinostat

Contact Research Centre

Kidney transplant rejection

Not recruiting

Registered drugNo placebo

Study on Imlifidase for Highly Sensitized Patients with End-Stage Chronic Kidney Disease Awaiting Transplant

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Imlifidase

Contact Research Centre

Plasma cell myeloma

Not recruiting

Registered drugNo placebo

Study on the Effects of Isatuximab with Bortezomib, Lenalidomide, and Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma Not Eligible for Transplant

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Bortezomib

Contact Research Centre

Focal segmental glomerulosclerosis

Not recruiting

Registered drugNo placebo

Study on the Effects of Sparsentan and Irbesartan for Patients with Primary Focal Segmental Glomerulosclerosis (FSGS)

Registered drugNo placebo

Sweden

Participants:0–17 years · 18–64 years · 65+ years
Substances:Irbesartan

Contact Research Centre

Plasma cell myeloma

Not recruiting

Registered drugNo placebo

Study on Isatuximab and CellProtect for Maintenance Treatment in Patients with Newly Diagnosed Multiple Myeloma Eligible for Stem Cell Transplant

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Evencaleucel

Contact Research Centre

Find therapies in clinical trials near you – page 13

216 trials match your criteria

Porphyria non-acute

Study on the Safety and Tolerability of Oral Dersimelagon for Patients with Erythropoietic Protoporphyria or X-Linked Protoporphyria

IgA nephropathy

Study on the Effectiveness and Safety of Iptacopan for Patients with Primary IgA Nephropathy

Plasma cell myeloma refractory

Study of Teclistamab for Patients with Relapsed or Refractory Multiple Myeloma

Acute myeloid leukaemia+1

Study Comparing Gilteritinib and Midostaurin with Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome with FLT3 Mutation

Neurodegenerative disorder

Study of Latozinemab for Patients with Neurodegenerative Diseases Who Previously Participated in a Latozinemab Study

Demyelination

Study on the Effectiveness and Safety of Rozanolixizumab for Adults with Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOG-AD)

Plasma cell myeloma

Study Comparing Teclistamab, Talquetamab, and Drug Combination for Patients with Newly Diagnosed Multiple Myeloma Not Suitable for Stem Cell Transplant

Polycythaemia vera+10

Study on Long-Term Safety of Ruxolitinib, Panobinostat, and Siremadlin for Patients Continuing Treatment from Previous Studies

Kidney transplant rejection

Study on Imlifidase for Highly Sensitized Patients with End-Stage Chronic Kidney Disease Awaiting Transplant

Plasma cell myeloma

Study on the Effects of Isatuximab with Bortezomib, Lenalidomide, and Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma Not Eligible for Transplant

Focal segmental glomerulosclerosis

Study on the Effects of Sparsentan and Irbesartan for Patients with Primary Focal Segmental Glomerulosclerosis (FSGS)

Plasma cell myeloma

Study on Isatuximab and CellProtect for Maintenance Treatment in Patients with Newly Diagnosed Multiple Myeloma Eligible for Stem Cell Transplant

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.